Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock

Benedikt Schrage1,2, Peter Moritz Becher1,2, Alina Goßling1

  • 1Department of Cardiology, University Heart and Vascular Centre Hamburg, Martinistr. 52, Hamburg, 20246, Germany.

ESC Heart Failure
|February 19, 2021
PubMed

Insights

Cardiogenic shock incidence is rising in Germany, with changing causes and persistently high mortality. Despite advances in mechanical support, outcomes remain poor, especially for non-myocardial infarction causes.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Public Health

Background:

  • Cardiogenic shock (CS) management is challenging, characterized by high mortality rates.
  • Despite innovations, effective strategies for CS remain elusive, necessitating further research.

Purpose of the Study:

  • To analyze temporal trends in CS incidence, causes, mechanical circulatory support (MCS) utilization, and mortality in Germany.
  • To identify shifts in CS etiology and treatment patterns over time.

Main Methods:

  • Retrospective analysis of nationwide data from German hospitals (2005-2017).
  • Inclusion of 441,696 patients diagnosed with cardiogenic shock.
  • Statistical analysis of incidence, causes, MCS use (IABP, ECMO, VADs), and mortality rates.

Main Results:

  • CS incidence increased from 33.1 to 51.7 per 100,000 population.
  • Acute myocardial infarction (AMI) remained a primary cause, but its proportion decreased.
  • Use of extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs) significantly increased, while intra-aortic balloon pump (IABP) use declined.
  • Overall mortality remained high (~60%), with slight improvement in AMI-related CS but no significant change in non-AMI CS.

Conclusions:

  • CS incidence is increasing in Germany, with evolving causes and high mortality.
  • Despite increased use of advanced MCS, overall mortality remains a critical concern.
  • There is a pressing need for improved evidence-based strategies, particularly for CS not caused by AMI.
Abstract

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
250
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
238
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
210
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
145